Insiders trading at Revance Therapeutics Inc
Over the last 10 years, insiders at Revance Therapeutics Inc have traded over $28,926,756 worth of Revance Therapeutics Inc stock and bought 106,530 units worth $1,804,647 . The most active insiders traders include Vlad Coric, Julian S Gangolli, and Angus C. Russell. On average, Revance Therapeutics Inc executives and independent directors trade stock every 30 days with the average trade being worth of $88,444. The most recent stock trade was executed by Dwight Moxie on 5 September 2023, trading 34,853 units of RVNC stock currently worth $612,716.
